These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 30801691)
1. Signalling in response to sub-picomolar concentrations of active compounds: Pushing the boundaries of GPCR sensitivity. Civciristov S; Halls ML Br J Pharmacol; 2019 Jul; 176(14):2382-2401. PubMed ID: 30801691 [TBL] [Abstract][Full Text] [Related]
2. GPCR signalling from within the cell. Jong YI; Harmon SK; O'Malley KL Br J Pharmacol; 2018 Nov; 175(21):4026-4035. PubMed ID: 28872669 [TBL] [Abstract][Full Text] [Related]
3. Structural commonality of C1q TNF-related proteins and their potential to activate relaxin/insulin-like family peptide receptor 1 signalling pathways in cancer cells. Klonisch T; Glogowska A; Thanasupawat T; Burg M; Krcek J; Pitz M; Jaggupilli A; Chelikani P; Wong GW; Hombach-Klonisch S Br J Pharmacol; 2017 May; 174(10):1025-1033. PubMed ID: 27443788 [TBL] [Abstract][Full Text] [Related]
4. Signal transduction pathways activated by insulin-like peptide 5 at the relaxin family peptide RXFP4 receptor. Ang SY; Hutchinson DS; Patil N; Evans BA; Bathgate RAD; Halls ML; Hossain MA; Summers RJ; Kocan M Br J Pharmacol; 2017 May; 174(10):1077-1089. PubMed ID: 27243554 [TBL] [Abstract][Full Text] [Related]
5. Superagonism at G protein-coupled receptors and beyond. Schrage R; De Min A; Hochheiser K; Kostenis E; Mohr K Br J Pharmacol; 2016 Oct; 173(20):3018-27. PubMed ID: 26276510 [TBL] [Abstract][Full Text] [Related]
6. Unravelling G protein-coupled receptor signalling networks using global phosphoproteomics. Pokhrel R; Morgan AL; Robinson HR; Stone MJ; Foster SR Br J Pharmacol; 2024 Jul; 181(14):2359-2370. PubMed ID: 36772927 [TBL] [Abstract][Full Text] [Related]
7. Integrating the GPCR transactivation-dependent and biased signalling paradigms in the context of PAR1 signalling. Little PJ; Hollenberg MD; Kamato D; Thomas W; Chen J; Wang T; Zheng W; Osman N Br J Pharmacol; 2016 Oct; 173(20):2992-3000. PubMed ID: 26624252 [TBL] [Abstract][Full Text] [Related]
8. Biased agonists of GPR84 and insights into biological control. Luscombe VB; Wang P; Russell AJ; Greaves DR Br J Pharmacol; 2024 May; 181(10):1509-1523. PubMed ID: 38148720 [TBL] [Abstract][Full Text] [Related]
9. Distribution, physiology and pharmacology of relaxin-3/RXFP3 systems in brain. Ma S; Smith CM; Blasiak A; Gundlach AL Br J Pharmacol; 2017 May; 174(10):1034-1048. PubMed ID: 27774604 [TBL] [Abstract][Full Text] [Related]
10. The current state of GPCR-based drug discovery to treat metabolic disease. Sloop KW; Emmerson PJ; Statnick MA; Willard FS Br J Pharmacol; 2018 Nov; 175(21):4060-4071. PubMed ID: 29394497 [TBL] [Abstract][Full Text] [Related]
11. Stimulation of β-adrenoceptors up-regulates cardiac expression of galectin-3 and BIM through the Hippo signalling pathway. Zhao WB; Lu Q; Nguyen MN; Su Y; Ziemann M; Wang LN; Kiriazis H; Puthalakath H; Sadoshima J; Hu HY; Du XJ Br J Pharmacol; 2019 Jul; 176(14):2465-2481. PubMed ID: 30932177 [TBL] [Abstract][Full Text] [Related]